BackSupernus Pharmaceuticals Overview

Supernus Pharmaceuticals Total Revenue

Revenue analysis for SUPN.

Quarterly Revenue

$207.71M
↑ 38.63% YoY

As of Mar 2026

Annual Revenue (TTM)

$192.69B
↑ 28745.6% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin